참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Dimethyl Sulfoxide | HCID 679 | — |
| 반응물 | Piperazine | HCID 4837 | — |
| 반응물 | 2-chloro-6-(trifluoromethyl)-1H-benzimidazole | HCID 337905 | — |
| 용매 | Water | HCID 962 | — |
| 생성물 | 2-Piperazin-1-yl-6-trifluoromethyl-1H-benzoimidazole | HCID 11666201 | — |
반응 단계
A mixture of 2-chloro-6-trifluoromethyl-1H-benzoimidazole (221 mg, 1 mmol, Example 1c), piperazine (172 mg, 2 mmol, Aldrich) and DMSO (2 mL) was stirred at 80° C. for 24 h. The mixture was cooled to room temperature, water (10 mL) was added and the mixture was extracted with EtOAc (2×20 mL). The combined organic phases were washed with water (2×5 mL) and brine (5 mL), dried over Na2SO4, and filtered. The solvent was removed in vacuo and the residue was purified by silica gel chromatography, eluting with 10% MeOH/CH2Cl2+1% ammonia (30% in water) to give the title compound. MS (ESI, pos. ion) m/z: 271 (M+1).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07582761B2 |
|---|
| 출처 데이터셋 | uspto-grants-2009_09 |
|---|
| ORD ID | ord-e86feb2cc7564c5fb9120f920da27bee |
|---|
| 출처 메모 | uspto-grants-2009_09 |
|---|